News

SYN-005 is being developed through Synthetic Biologics’ exclusive channel collaboration with Intrexon (XON) and academic researchers at the University of Texas at Austin to target and neutralize the

Made from allogeneic human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCB-MSCs), PNEUMOSTEM is expected to have effect on regenerating the lung tissue and improving inflammatory responses in premature

Hyqvia is a combination of Immune Globulin Infusion 10% (Human) (IG 10%) and Recombinant Human Hyaluronidase developed by Halozyme. The first subcutaneous immune globulin (IG) treatment is approved

CLT-008 is a first-in-class, allogeneic, cell-based therapy to treat hematopoietic sub-syndrome of Acute Radiation Syndrome (ARS). The recent funding is in addition to the $116.4m committed under the

The approval allows the tablets for use in chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27

The discovery of dendritic cells in 1973, resulting in a 2011 Nobel Prize in Physiology or Medicine, bridged the two principal aspects of immunity (innate and adaptive) first

The Company will use the information generated to advance one or more candidates into formal development studies in the coming months. Prosonix’ MCP Technology allows the combination of

These grants support a global intellectual property estate broadly covering the Company’s biochemistry and delivery technologies with over 100 issued or allowed patents and over 90 pending U.S.

The supplement features a discussion on available clinical evidence from trials conducted in patients with diabetic foot ulcers (DFUs). The authors, Dr. Lawrence Lavery, Professor of Surgery, University